Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Lesion Dosimetry for [(177)Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.
Grkovski M, O'Donoghue JA, Imber BS, Andl G, Tu C, Lafontaine D, Schwartz J, Thor M, Zelefsky MJ, Humm JL, Bodei L. Grkovski M, et al. Among authors: tu c. J Nucl Med. 2023 Nov;64(11):1779-1787. doi: 10.2967/jnumed.123.265763. Epub 2023 Aug 31. J Nucl Med. 2023. PMID: 37652541 Free PMC article.
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility of combining [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy (RPT) with stereotactic body radiotherapy (SBRT) for the treatment of oligometastatic castration-sensitiv …
A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility of combining [(177)Lu]Lu-PS …
Linear Boltzmann equation solver for voxel-level dosimetry in radiopharmaceutical therapy: Comparison with Monte Carlo and kernel convolution.
Kayal G, Van B, Andl G, Tu C, Wareing T, Wilderman S, Mikell J, Dewaraja YK. Kayal G, et al. Among authors: tu c. Med Phys. 2024 Mar 4. doi: 10.1002/mp.16996. Online ahead of print. Med Phys. 2024. PMID: 38436493
To evaluate the performance of the LBTE solver for RPT and SIRT applications, (177) Lu SPECT/CT, (90) Y PET/CT, and (131) I SPECT/CT images of phantoms and patients were used. ...The LBTE and OLINDA estimates for mean absorbed dose in kidneys and liver agreed to within 10% …
To evaluate the performance of the LBTE solver for RPT and SIRT applications, (177) Lu SPECT/CT, (90) Y PET/CT, and (131) I SPECT/CT …